2010 Publications

NoTitleAuthorsYear
1A cluster randomized trial of routine HIV-1 viral load monitoring in Zambia: study design, implementation, and baseline cohort characteristicsKoethe JR, Westfall AO, Luhanga DK, Clark GM, Goldman JD, Mulenga PL, Cantrell RA, Chi BH, Zulu I, Saag MS, Stringer JSA2010
2A cluster-randomized trial of enhanced labor ward-based PMTCT services to increase nevirapine coverageMegazzini KM, Sinkala M, Vermund SH, Redden DT, Krebs DW, Acosta EP, Mwanza J, Goldenberg RL, Chintu N, Bulterys M, Stringer JSA2010
3An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programsChi BH, Cantrell RA, Mwango A, Westfall AO, Mutale W, Limbada M, Mulenga LB, Vermund SH, Stringer JSA2010
4Antiretroviral therapies in women after single-dose nevirapine exposureLockman S, Hughes M, McIntyre, Zheng Y, Chipato T, Conradie F, Sawe F, Asmelash, A, Hosseinipour M, Mohapi L, Stringer E, Mngibisia R, Siika A, Atwine D, Hakim J, Shaffer D, Kanyama C, Wools-Kaloustian K, Salata R, Hogg E, Alston-Smith B, Walawander A, Purcelle-Smith E, Eshleman S, Rooney J, Rahim S, Mellors J, Schooley R, Currier J2010
5Antiretroviral therapy in antenatal care to increase treatment initiation in HIV-infected pregnant women: a stepped-wedge evaluationKillam WP, Tambatamba B, Chintu N, Rouse D, Stringer E, Bweupe M, Yu Y, Stringer JSA2010
6Antiretroviral treatment for children with peripartum nevirapine exposurePalumbo P, Lindsey J, Hughes M, Cotton M, Bobat R, Meyers T, Bwakura-Dangarembizi M, Chi BH, Musoke P, Kamthunzi P, Schimana W, Purdue L, Eschleman S, Abrams E, Millar L, Petzold E, Mofenson L, Jean-Phillippe P, Violari A2010
7Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic reviewChamot E, Kristensen S, Stringer JSA, Mwanahamuntu MH2010
8Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, ZambiaKoethe JR, Lukusa A, Giganti MJ, Chi BH, Nyirenda CK, Limbada MI, Banda Y, Stringer JSA2010
9Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trialFuchs J, Celum C, Wang J, Hughes J, Sanchez J, Cowan F, Reid S, Delany-Moretlwe S, Corey L, Wald A; HIV Prevention Trials Network 039 Protocol Team2010
10Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countriesStringer EM, Ekouevi DK, Coetzee D, Tih PM, Creek TL, Stinson K, Giganti MJ, Welty TK, Chintu N, Chi BH, Wilfert CM, Shaffer N, Dabis F, Stringer JSA2010
11Differences in presentation, treatment initiation, and response among children infected with human immunodeficiency virus in urban and rural ZambiaSutcliffe CG, van Dijk JH, Bolton-Moore C, Cotham M, Tambatamba B, Moss WJ2010
12Early CD4+ lymphocyte recovery and subsequent mortality among malnourished adults initiating antiretroviral therapy in Lusaka, ZambiaKoethe JR, Limbada MI, Giganti MJ, Nyirenda CK, Mulenga LB, Wester CW, Chi BH, Stringer JSA2010
13Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in ZambiaChi BH, Mwango A, Giganti M, Mulenga LB, Tambatamba-Chapula B, Reid SE, Bolton-Moore C, Chintu N, Mulenga PL, Stringer EM, Sheneberger R, Mwaba P, Stringer JSA2010
14eC3—a modern telecommunications matrix for cervical cancer prevention in ZambiaParham GP, Mwanahamuntu MH, Pfaendler KS, Sahasrabuddhe VV, Myung D, Mkumba G, Kapambwe S, Mwanza B, Chibwesha C, Hicks ML, Stringer JSA2010
15Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infectionKim HN, Wang J, Hughes J, Coombs R, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Fuchs J, Eshleman SH, Khaki L, McMahon MA, Siliciano RF, Wald A, Celum C2010
16Effectiveness of a program to prevent cervical cancer among HIV-infected women in ZambiaParham GP, Mwanahamuntu MH, Sahasrabuddhe VV, Westfall AO, King KE, Mudenda M, Pfaendler KS, Chibwesha C, Mkumba G, Kapambwe S, Vermund SH, Hicks ML, Stringer JSA, Chi BH2010
17Effectiveness of non-nucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in women previously exposed to a single intrapartum dose of nevirapine: a multi-country, prospective cohort studyStringer JSA, McConnell MS, Kiarie J, Bolu O, Anekthananon T, Jariyasethpong T, Zulu I, Njobvu L, Jetsawang B, Pathak S, Bulterys M, Shaffer N, Weidle PJ2010
18Fasting triglyceride concentrations are associated with early mortality following antiretroviral therapy in ZambiaNgu JN, Heimburger DC, Arnett DK, Nyirenda CK, Potter D, Zulu I, Bosire CN, Bagchi S, Ye J, Chi BH, Kabagambe EK2010
19How late is too late? Timeliness to scheduled visits as an antiretroviral therapy adherence measure in Nairobi, Kenya and Lusaka, ZambiaBlacher RJ, Muiruri P, Njobvu L, Mutsotso W, Potter D, Ong'ech J, Mwai P, Degroot A, Zulu I, Bolu O, Stringer JSA, Kiarie J, Weidle PJ2010
20Interventions to prevent breastfeeding transmission of HIV-1Slater M, Stringer EM, Stringer JSA2010
21Methods and baseline results of a repeated cross-sectional survey to assess the public health impact of antiretroviral therapy in Lusaka, ZambiaGiganti M, Levy JW, Banda Y, Kusanthan T, Sinkala M, Stringer JSA, Chi BH2010
22Mobile phones to improve HIV treatment adherenceChi BH, Stringer JSA2010
23Myths and misconceptions about cervical cancer among Zambia women: rapid assessment by peer educatorsChirwa S, Mwanahamuntu M, Kapambwe S, Mkumba G, Stringer J, Sahasrabuddhe V, Pfaendler K, Parham G2010
24Nevirapine-associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and KenyaPeters PJ, Stringer JSA, McConnell MS, Kiarie J, Ratanasuwan W, Intalapaporn P, Potter D, Mutsotso W, Zulu I, Borkowf CB, Bolu O, Brooks JT, Weidle PJ2010
25Peripartum nevirapine exposure and subsequent clinical outcomes among HIV-infected women receiving antiretroviral therapy for at least 12 monthsChintu N, Giganti MJ, Putta NB, Sinkala M, Sadoki E, Stringer EM, Stringer JSA, Chi BH2010
26Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African womenReid SE, Dai JY, Wang J, Bichalwe BN, Akpomiemie G, Cowan FM, Delany-Moretlwe S, Baeten JM, Hughes JP, Wald A, Celum C2010
27Secular trends in pediatric antiretroviral treatment programs in rural and urban Zambia: a retrospective cohort studySutcliffe CG, Bolton-Moore C, van Dijk JH, Cotham M, Tambatamba B, Moss WJ2010
28Serum phosphate predicts early mortality in adults starting antiretroviral therapy in Lusaka, Zambia: a prospective cohort studyHeimburger DC, Koethe JR, Nyirenda C, Bosire C, Chiasera JM, Blevins, Munoz AJ, Shepherd B, Potter D, Zulu I, Chisembele-Taylor A, Chi BH, Stringer JSA, Kabagambe EK2010
29Sex steroid hormone, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infectionHel Z, Stringer E, Mestecky J2010
30Strengthening health systems at facility-level: feasibility of integrating antiretroviral therapy into primary health care services in Lusaka, ZambiaTopp SM, Chipukuma JM, Giganti M, Mwango LK, Chiko LM, Tambatamba-Chapula B, Wamulume CS, Reid S2010
31Transmission of HIV to infants whose mothers seroconvert postnatallyStringer JSA, Guffey MB2010
32Treatment of trichomoniasis in pregnancy in sub-Saharan Africa does not appear to be associated with low birth weight or preterm birthStringer E, Read JSA, Hoffman I, Valentine M, Aboud S, Goldenberg RL2010
33Validation of rapid HIV antibody tests in 5 African countriesPiwowar-Manning EM, Tustin NB, Sikateyo P, Kamwendo D, Chipungu C, Maharaj R, Mushanyu J, Richardson BA, Hillier S, Jackson JB2010
34Koethe JR, Heimburger DCPMCID: PMC28564782010